- Media Sphera
- Publishers
Launch year: 1983 The journal covers relevant theoretical and practical aspects of the molecular genetics of prokaryotic and eukaryotic organisms, molecular microbiology, and molecular virology.
Language of publication: Russian. English version of the most interesting articles is marked as En-version and available in free access in PDF.
Launch year: 1983
The journal covers relevant theoretical and practical aspects of the molecular genetics of prokaryotic and eukaryotic organisms, molecular microbiology, and molecular virology.
The journal’s scope includes the following:
The journal aims to disseminate research findings on genetic engineering, including synthesis and isolation of genes from natural foci, creation of plasmoid- and virus-based vectors, and obtaining of recombinant DNA molecules for establishing gene banks of microorganisms, animals, and humans. It also seeks to publish articles on the biotechnological production of hormones, components of antiviral vaccines, and diagnostic and therapeutic preparations. In addition to original articles, each issue contains literature and book reviews, news, and information on congresses and conferences. The Molecular Genetics, Microbiology and Virology Journal was launched in 1983. Since 1988, it is translated into English and distributed to subscribers outside Russia. Since 2007, the journal has been translated by the International Academic Publishing Company Nauka / Interperiodica. Both print and electronic versions are available by subscription. The journal is intended for researchers, academics, and doctors interested in the problems of molecular genetics, microbiology, virology, and cancer proteomics.
The journal is following publishing and journal best practices of these organizations:
Journal is indexed in the following international databases and information and reference publications: Russian Science Citation Index (RSCI), Web of Science (Science Citation Index Expanded (SciSearch), Journal Citation Reports/Science Edition), SCOPUS, EMBASE, Google Scholar, Biological Abstracts, BIOSIS, CNKI, EBSCO Discovery Service, Expanded Academic, Gale, Gale Academic OneFile, Health Reference Center Academic, OCLC, ProQuest - Summon, ProQuest Biological Science Database, ProQuest Natural Science Collection, ProQuest SciTech Premium Collection, Reaxys.
Frequency: 4 issues per year
English version of the journal:
https://www.springer.com/life+sciences/microbiology/journal/11965
Electronic ISSN: 1934-841X
Print ISSN: 0891-4168
1. Russian Science Citation Index
Analysis of the journal's publication activity
2. Scopus CiteScore
Infectious Diseases
Molecular Biology
Microbiology
3. SJR (Scimago Journal & Country Rank)
Solving all issues through the electronic edition service
Additional services in preparing of articles for publishing
Consultations about publishing ethics
Mikhail V. Kovalchuk
Editor-in-Chief, Corr. Member of the RAS, Doctor of Physics and Mathematics, President of the National Research Center “Kurchatov Institute” (Moscow, Russia)
Yulia M. Romanova
Deputy Editor-in-Chief, Prof., PhD, Leading Researcher, N.F. Gamaleya Federal Research Center for Epidemiology and Microbiology (Moscow, Russia)
Tamilla S. Ilyina
Executive Secretary, Prof., PhD, Senior researcher, N.F. Gamaleya Federal Research Center for Epidemiology and Microbiology (Moscow, Russia)
Vadim I. Agol
Prof., Corr. Member of the RAS, D.Biol.Sc., Chief Scientist, Chumakov Federal Scientific Center for Research and Development of Immunobiological Products, Russian Academy of Sciences; Head, Department of Virus-Cell Interactions, A. N. Belozersky Research Institute of Physical-Chemical Biology, M. V. Lomonosov Moscow State University (Moscow, Russia)
Anatoly D. Altshteyn
Prof., MD, PhD, N.F.Gamaleya FSRC of epidemiology and microbiology (Moscow, Russia)
Andrey P. Anisimov
Prof., MD, PhD, Deputy Director for Science, State Research Center for Applied Microbiology and Biotechnology (Obolensk, Russia)
Vladimir A. Gvozdev
Acad. of the RAS, PhD, Head of Department of Molecular Genetics of Cells, Institute of Molecular Genetics of the Russian Academy of Sciences (Moscow, Russia)
Aleksandr L. Ginzburg
Prof., Acad. of the RAS, MD, PhD, Head of N.F. Gamaleya Federal Research Center for Epidemiology and Microbiology (Moscow, Russia)
Ilya V. Demidyuk
Professor of RAS, PhD, Deputy Director of the Institute of Molecular Genetics of the Russian Academy of Sciences (Moscow, Russia)
Vladimir V. Demkin
PhD, Head of Center for cellular and genetic technologies, Institute of Molecular Genetics, Russian Academy of Sciences (Moscow, Russia)
Andrey V. Karlyshev.
Senior researcher, PhD, Professor of Microbiology, Department of Biomolecular Sciences, SEC Faculty, School of Life Sciences, Pharmacy and Chemistry, Kingston University London (London, United Kingdom)
Svetlana A. Limborskaya
Prof., PhD, Department of Molecular Bases of Human Genetics, Institute of Molecular Genetics, Russian Academy of Sciences (Moscow, Russia)
Sergey A. Lukyanov
Acad. of the RAS, PhD, Deputy Director, M.M. Shemyakin – Yu.A. Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences (Moscow, Russia)
Vladimir L. Motin
Prof., PhD, Head of the Laboratory, University of Texas Medical Brach (Galveston, USA)
Nikolai F. Myasoedov
Acad. of the RAS, PhD, Head of Department of Chemistry of Physiologically Active Agents, Institute of Molecular Genetics of Russian Academy of Science (Moscow, Russia)
Sergey V. Netesov
Prof., Acad. of the RAS, PhD (Chemistry), D.Sci. (Biology), Head of Laboratory of Biotechnology and Virology, Faculty of Natural Sciences, Novosibirsk State University (Novosibirsk, Russia)
Evgeny D. Sverdlov
Prof., Acad. of the RAS, PhD, Advisor of the Russian Academy of Sciences in Institute of Molecular Genetics of Russian Academy of Sciences, Head of Laboratory of Human Genes Structure and Functions, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of Russian Academy of Sciences (Moscow, Russia)
Georgy B. Smirnov
Prof., PhD, Chief Researcher of the Institute of PhysicoChemical Medicine of the Federal Medical and Biological Agency (Moscow, Russia)
Nina I. Smirnova
Prof., Doctor of Biological Sciences, Head of Microbiology Department, Head of the Laboratory, Russian Research Anti-Plague Institute «Microbe» (Saratov, Russia)
Vyacheslav Z. Tarantul
Prof., PhD, Head of Department, Institute of Molecular Genetics of the Russian Academy of Sciences (Moscow, Russia)
Maksim M. Shmarov
PhD, D.Sc., Head of laboratory of molecular biotechnology, National Centre for Epidemiology and Microbiology named after the honorary academician N.F. Gamaleya» of the Ministry of Health of the Russian Federation (Moscow, Russia)
Aleksandr M. Boronin
Prof., PhD, Еditorial council, Head of the Skryabin Institute of Biochemistry and Physiology of Microorganisms of the Russian Academy of Sciences, Moscow region, Pushchino (Russia)
Aleksandr A. Prozorov
Prof., PhD, Еditorial council, Vavilov Institute of General Genetics of the Russian Academy of Sciences (Russia)
Sergey V. Shestakov
Prof., Acad. of the RAS, PhD, Еditorial council, Department of Genetics, Biological Faculty, Lomonosov Moscow State University (Russia)
There is no fee for the publication of manuscripts.
By submitting an article to the publisher, the author agrees to the terms of the CONTRACT OFFER.
When preparing a manuscript, authors should follow Recommendations on conducting, describing, editing and publishing the results of scientific work in medical journals of the International Committee of Medical Journal Editors (ICMJE).
When reviewing an article, the editorial board can check the material using Anti-plagiarism system. If multiple borrowings are found, the editorial board acts according to the rules COPE.
In preparing the manuscript, authors should follow the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals of the International Committee of Medical Journal Editors.
The Editorial Board checks the material using the Anti-Plagiarism system. In the case of multiple borrowings, the Editorial Board operates in accordance with COPE Recommendations.
Submitted manuscripts should be signed by the head of the host organization. An official referral should also be provided (download a blank form of the referral - MS Word.doc), specifying if the article is a part of the author's thesis.
One cannot submit a paper previously accepted or published elsewhere.
Authors are responsible for disclosing financial or other potential conflict of interests that might bias or be seen to bias their work.
The authors are required to indicate the role of sponsors or funders in each of the following: study design, collection and analysis of data, and making the decision to publish the results. If neither the sponsor, nor the funder played such a role, this should be stated in the referral (see above).
It is prohibited to publish patient-identifiable information, i.e. his/her name, initials, or case number on photographs or in illness descriptions and family trees, except for the cases of paramount scientific interest and an informed consent given by the patient or his (her) parents or guardians. Obtaining the informed consent should be stated in the article.
For experiments involving human subjects the authors should specify whether they conform to the local or regional ethical standards as well as to the ethical standards accepted by the 1975 Helsinki Declaration and also the 2000 revised version.
For experiments involving laboratory animals the authors should specify whether they conform to the husbandry conditions accepted by the host organization, recommendations of the national research council, and national legislation.
2. The editors retain the customary right to shorten and alter submitted manuscripts. A manuscript is considered registered on the date its final variant (revised in accordance with the recommendations of the Editorial Staff or the reviewer) is received.
are sent to MGMV12@yandex.ru, molgenetika@yandex.ru.
To submit a manuscript, please, prepare the following:
Each figure should be attached as a separate TIFF, JPEG or PNG image. As to figures that were created or processed using Microsoft Office tools (WORD or POWER POINT), they should be attached as separate files with corresponding extensions (.doc, .docx, .ppt). File names should be given according to figure numbers in the text (e.g., Fig-1, Fig-2a, Fig-2, etc.). Our online submission and editorial system requires that all your images were downloaded as a single .zip or .rar archive.
Captions for figures and photos, notes must be in Russian and English and should be grouped together at the end of the article. General descriptions and the key to abbreviations should be provided.
Graph legends should explain the designation of axes and units of measurements. Micrograph captions should indicate the staining method and magnification.
We insist that you send only high-quality images. Please, make sure of high image resolution and large enough letters typed in the images (remember that they should be easy to read when printed).
Articles should be typed in Times New Roman or Arial (14 pt size, 1.5 spaced, left margin set at 3 cm, other margins - 2 cm). Pages should be enumerated. Automatic hyphenation is not allowed.
An article SHOULD NOT EXCEED 18 pages (including illustrations, tables, an abstract and references), review or advisory letter – 3 pages.
In case of multiple authorship a numerical footnote should be applied to each author's surname indicating his/her place of work. If all authors work in the same organization it is not necessary to cite their place of work for each of them.
This information should be presented in both Russian and English. It is recommended that the authors’ surnames are spelled as in their previous publications or transliterated in accordance with the BSI standards (British Standards Institution), see http://ru.translit.net/?account=bsi. As to organizations, the official English name should be provided.
A separate page should contain additional information on each of the authors as required by the Russian Science Citation Index: surname, first and patronymic names in Russian and transliterated, e-mail and postal address of the organization for correspondence with the authors (can be one for all authors). For better correspondence, please, provide contacts of one of the authors, including e-mail and mobile phone number. Also you must specify the ORCID for the author who submits the article, and preferably for each author of the article. If there is no ORCID number, you need to obtain it by registering at https://orcid.org/. We recommend to check the correct spelling of the institution's name on the site https://grid.ac.
ФУНКЦИОНАЛЬНАЯ МИТРАЛЬНАЯ НЕДОСТАТОЧНОСТЬ У БОЛЬНЫХ С АОРТАЛЬНЫМИ ПОРОКАМИ СЕРДЦА: СОВРЕМЕННОЕ СОСТОЯНИЕ ПРОБЛЕМЫ
Акад. РАН Ю.В. Белов, д.м.н. Э.Р. Чарчян, Г.И. Салагаев
ФГБНУ «Российский научный центр хирургии им.акад.Б.В.Петровского»
Functional mitral regurgitation in aortic valve disease patients: state of the art
Acad. Of RAS Yu. V. Belov, E.R. Charchyan, G.I. Salagaev
B.V.Petrovsky Russian Research Center of Surgery (director – academician of RAS Yu.V.Belov); Department of aortic Surgery of the B.V. Petrovsky Russian Research Center of Surgery (head – E.R. Charchyan), Moscow, Russia
The COMPOSITION of an original article should be the following: an abstract and key words (in both Russian and English), short introduction describing the current state of the problem, aim, material and methods, results and discussion, enumerated findings or conclusion, references.
The article should be brief and clear. It should not contain long historical reviews or reiterations.
The manuscript can be supplemented by a glossary (for unobvious terminology).
Besides generally accepted abbreviations and acronyms of units of measurement as well as physical, chemical, and mathematical quantities and terms (e.g. DNA), one can introduce abbreviations of own expressions frequently used in the article. All abbreviations introduced by the author are to be expanded at first mention. Simple words must not be contracted, even if they are often repeated in the text.
Drug doses, units of measurement, and other numerical values should be provided in accordance with the International System of Units (SI).
7. AUTHOR'S SUMMARY (ABSTRACT)
An abstract is the basic information source for Russian and foreign information systems and databases. Despite its necessary brevity, an abstract, like a business card, is meant to be exhaustive. Judging from the abstract, the editor decides whether or not the article is worth reviewing. After the article is published, most potential readers (up to 95% by some estimates) will not read beyond the abstract. Thus, it should be able to explain the essence of the study to the reader and entice him/her into obtaining a copy of the full paper for more details. The size of the abstract depends on the amount of information in the article, its scientific value and/or practical importance, however, has to lie within the range of 200-250 words.
Structured abstract
A structured abstract is an essential part of any scientific article that contains experimental or quasi-experimental results, empirical evidence, or systematic review. Its informative value is usually higher than that of an ordinary unstructured abstract. It may be also easier to read and remember. Moreover, a structured abstract ensures higher visibility of the article in international databases, which ultimately influences its citation potential.
A structured abstract should include five sections in chronological order: Rationale, Aim, Methods, Results, and Discussion.
RATIONALE – a brief (1-3 sentences) description of the problem that necessitated the study. The problem can be characterized by its scale, mediated effects, and/or lack of scientific knowledge.
AIM – this section is to define the primary aim, or the main question of the study. Please, note that the aim should be as concrete as possible without boiling down to overall comparisons.
METHODS – this section is meant to provide the following information: 1) subject details (like whether the participants were diseased or healthy), 2) control group details if any, 3) inclusion criteria, 4) performed interventions, 5) study site and 6) duration, 7) outcomes (including measures that can be taken to determine their correspondence with the primary aim) and 8) evaluation methods. The necessity of specifying statistical tests and software will be addressed individually by the editor.
RESULTS – this section should provide further details on study participants (such as the number of those enrolled and those who completed the study as well as some major characteristics of the latter) and evaluate the outcomes that correspond with the primary aim. It is possible to present the results from 2-3 subgroups divided by age, sex, clinical features, etc. Adverse effects, if any, must be reported. Statistical measures (p value) should be given with an accuracy of three decimal places. When investigating multi-criteria relationships (e.g. one dependant and several independent variables), please, provide the results of multifactorial analyses.
CONCLUSION – a summary of study results that correspond with its primary aim (1-3 sentences). Authors are advised to avoid excessive generalization and balance their appraisal of positive and negative effects of an intervention.
A structured abstract should not exceed 250 words. Appropriateness of a larger abstract is discussed individually.
Commercial names of medical products are not allowed in the abstract.
Randomized trial
When reporting the results of a randomized trial, the CONSORT Statement should be complied with. Thus, an abstract is to include the following sections:
- study DESIGN
- METHODS
participants
interventions
objectives or study hypotheses
outcomes
randomization sequence generation
blinding (masking) (if applicable)
- RESULTS
number of randomized participants
numbers analyzed
outcomes and estimation (at the primary endpoint)
adverse events
- CONCLUSION
- study number (registration number; e.g. at clinicaltrials.com)
- funding source
Systematic review
Abstracts of systematic reviews should follow PRISMA recommendations (for reviewing randomized trials) and include the following sections:
- AIM or OBJECTIVES
- METHODS
inclusion criteria
data sources
study eligibility criteria
- RESULTS
review of relevant studies
synthesis of results
effect and sensitivity analysis
- DISCUSSION
summary of evidence and analysis (consistency, accuracy, generalizability, risk of bias)
interpretation of results
- funding source
- study number (registration number; e.g. at clinicaltrials.com)
Unstructured abstract
Non-systemic reviews, case reports, and opinion articles usually have unstructured abstracts. Narrative logic should, however, remain: one proceeds from presenting the problem to suggesting a solution and describing own results. Unstructured abstracts should not exceed 150 words.
Keywords should reflect the topic of the article. One can use some particular terms from the text, key terms in the field, or other relevant expressions able to improve search results. It is not recommended to repeat words from the title.
8. TABLES DESIGN. All tables should be enumerated and named. Clipped words are not allowed. Data in the table must be coincident with corresponding data in the text and treated statistically. The tables may be given either in the text, or on separate pages.
Signatures and all text data must be sent in Russian and English!
9. REFERENCE LISTS are to be prepared in accordance with the Uniform Requirements for Manuscripts Submitted to Biomedical Journals of the International Committee of Medical Journals Editors (ICMJE). Reference accuracy guarantees that the citations will be taken into account when assessing scientific public activity of the corresponding authors and their host organizations.
The maximum number of references for original articles is 30, literature reviews - 60, lectures and other materials – 15. Besides fundamental works, the list should include relevant publications over the last 5 years.
References should be numbered and ordered sequentially as they appear in the text.
In-text reference numbers should be in square brackets.
References to unpublished works are not allowed.
According to new reference guidelines that consider requirements of Web of Science and Scopus indices, bibliographic descriptions for Non-Latin References should be provided in not only their source languages, but also in Latin.
Thus, in order to be included in citation indices and DOI-CrossRef system, reference lists should be displayed as described below.
For example:
Литература/References
1. Медведев Б.И., Сюндюкова Е.Г., Сашенков С.Л. Плацентарная экспрессия эритропоэтина при преэклампсии. Российский вестник акушера-гинеколога. 2015;15:1:4-8. [Medvedev BI, Syundyukova EG, Sashenkov SL. Placental expression of erythropoietin in preeclampsia. Rossiiskii vestnik akushera-ginekologa. 2015;15:1:4-8. (In Russ.).] https://doi.org/10.17116/rosakush20151514-8
2. Matsumoto K, Nakamaru M, Obara H, Hayashi S, Harada H, Kitajima M, Shirasugi N, Nouga K. Surgical Strategy for Abdominal Aortic Aneurysm with Concurrent Symptomatic Malignancy. World Journal of Surgery. 1999;23(3):248-251. https://doi.org/10.1007/pl00013189
When referencing a journal article, always include the DOI (Digital Object Identifier in the CrossRef system). DOI search should be done at http://search.crossref.org/ or https://www.citethisforme.com. To start the search, type in the English title of the article. The latter website is able to provide you with not only the DOI, but also a full bibliographic description in AMA style. One should keep in mind that most journal articles (including many Russian-language ones) published after 2013 are registered in the CrossRef system and have a DOI.
Preparing Russian-language references for importation into international citation indices.
1. Journal articles.
Authors’ surnames and initials as well as the English title of the article should be identical to those in the original publication. Journal name that follows should be transliterated according to the BSI standard (can be done automatically at http://ru.translit.net/?account=bsi). Then come publication details (year, volume, issue, and pages). Source language should be indicated in parentheses. At the end of the description, the DOI should be given (if available). For example:
... [Belaia Z, Rozhinskaia L, Mel'nichenko G, Sitkin I, Dzeranova L, Marova E, Vaks V, Vorontsov A, Il'in A, Kolesnikova G, Dedov I. The role of prolactin gradient and normalized ACTH/prolactin ratio in the improvement of sensitivity and specificity of selective blood sampling from inferior petrosal sinuses for differential diagnostics of ACTH-dependent hypercorticism. Problemy endokrinologii. 2013;59(4):3-10. (In Russ.).] https://doi.org/10.14341/probl20135943-10
One should not cite journal articles that have no English title.
Citations from theses, theses abstracts, conference proceedings, etc. are not allowed.
2. All other sources should be transliterated according to the BSI standards but preserving their original stylesheets. Source language should be indicated in parentheses at the end of the description. Example: Gilyarevskii S.R. Miokardity: sovremennye podkhody k diagnostike i lecheniyu. M.: Media Sfera; 2008. (In Russ.).
Footnote: If the source was translated into English, please, indicate the translation, and not transliteration.
Please pay attention! The only correct form of doi-link:
https://doi.org/10.5468/ogs.2016.59.1.1
Do not use «doi:», «dx.doi.org», etc. Within the link only hyphen is used.
There is no dot after doi and URL!
For all your bibliographic entries, regardless the source language, please, apply the AMA Reference Style (http://www.amamanualofstyle.com).
Sample bibliographic entries:
Source type |
Russian-language material |
Non-Russian language material |
Regular journal article |
Белая Ж.Е., Рожинская Л.Я., Мельниченко Г.А., Ситкин И.И., Дзеранова Л.К., Марова Е.И., Вакс В.В., Воронцов А.В., Ильин А.В., Колесникова Г.С., Дедов И.И. Роль градиента пролактина и АКТГ/пролактин-нормализованного отношения для повышения чувствительности и специфичности селективного забора крови из нижних каменистых синусов для дифференциальной диагностики АКТГ-зависимого гиперкортицизма. Проблемы эндокринологии. 2013;59(4):3-10. [...] https://doi.org/10.14341/probl20135943-10 |
Vega K. Heart Transplantation Is Associated with an Increased Risk for Pancreaticobiliary Disease. Annals of Internal Medicine. 1996;124(11):980. https://doi.org/10.7326/0003-4819-124-11-199606010... |
Journal article within an appendix |
Самсонов С.Н., Петрова П.Г., Соколов В.Д., Стрекаловская А.А., Макаров Г.А., Иванов К.И. Гелиогеофизическая возмущенность и обострения сердечно-сосудистых заболеваний. Журнал неврологии и психиатрии им. С.С. Корсакова. 2005;(14)(прил. Инсульт):18-22.[...] |
Crinò L, Cappuzzo F. Present and future treatment of advanced non–small cell lung cancer. Seminars in Oncology. 2002;29(3)(suppl 9):9-16. https://doi.org/10.1053/sonc.2002.34266 |
Book (authors) |
Гиляревский С.Р. Миокардиты: современные подходы к диагностике и лечению. М.: Медиа Сфера; 2008.[...] |
Ringsven MK, Bond D. Gerontology and leadership skills for nurses. 2nd ed. Albany (NY): Delmar Publishers; 1996. |
Book (edited) |
Whole book: |
Whole book: |
Legal documents (draft laws, codes, resolutions, warrants, federal standards, rules) |
Федеральный закон Российской Федерации №323-Ф3 от 21 ноября 2011 г. «Об основах охраны здоровья граждан Российской Федерации». Ссылка активна на 12.12.2014. [...] http://www.rosminzdrav.ru/documents/7025-federalnyy-zakon-323-fz-ot-21-noyabrya-2011-g |
|
Patents |
Патент РФ на изобретение №2193864/ 10.12.02. Бюл. №34. Газазян М.Г., Пономарева Н.А., Иванова О.Ю. Способ ранней диагностики вторичной плацентарной недостаточности. Ссылка активна на 12.12.2014. [...] http://www.ntpo.com/patents_medicine/medicine_1/medicine_432.shtml |
Rabiner RA, Hare BA, inventors; OmniSonics Medical Technologies Inc, assignee. Apparatus for removing plaque from blood vessels using ultrasonic energy. US patent 6,866,670. March 15, 2005. |
Media and online materials |
Протокол исследования больных с нарушениями сна [архив]. Ссылка активна на 12.12.2014. [...] http://sleepmed.ru/protissl.zip |
Hormone replacement therapy [audio]. National Public Radio. August 5, 2002. Accessed March 4, 2004. http://www.npr.org/templates/story/story.php?storyId=1147833 |
Electronic journal article |
Полуэктов М.Г. Первичные и вторичные инсомнии и расстройства дыхания во сне. Журнал неврологии и психиатрии им. С.С. Корсакова. 2011;111(9)(2):10-18. Ссылка активна на 12.12.2014. [...] http://www.mediasphera.ru/journals/korsakov/detail/782/12404/ |
Duchin JS. Can preparedness for biological terrorism save us from pertussis? Arch Pediatr Adolesc Med. 2004;158(2):106-107. Accessed June 1, 2004. http://archpedi.ama-assn.org/cgi/content/full/158/2/106 |
10. For original articles with multiple authors please indicate on a separate page each author’s contribution to:
- study concept and design,
- data collecting and handling,
- statistical data analysis,
- writing,
- editing.
Example:
Authors: A.S. Ivanov, N.T. Petrov, K.I. Sidorov
Author’s contribution:
Study concept and design - A.I., K.S
Data collecting and handling - N.P.
Statistical data analysis - N.P
Text writing - K.S.
Editing - A.I
All the manuscripts submitted for publication in the journal are peer reviewed by two independent experts who are non-members of the Editorial Board of the journal.
The journal provides peer reviewing of all the submitted materials that are within the remit of the journal for expert evaluation. All peer reviewers are the acknowledged experts who specialize in the field relevant to the reviewed materials and have had publications relevant to the topic of the article being reviewed over the past 3 years. The peer reviews are stored in the publishing and editorial office for 5 years.
The article is sent to reviewers without names or contact information of the authors (the so-called blind review).
Reviewers treat the article as confidential material and strictly follow the author’s right for non-disclosure of the data reported in the manuscript before the article is published. The reviewer may engage additional experts only with permission from the Editorial Board and on a confidential basis.
Reviewers’ comments are sent to the author without disclosing the reviewers’ identity. The Editorial Board makes a final decision whether to publish the manuscript or not after the peer reviews and authors’ answers were received. The Editorial Board sends copies of peer reviews or a substantiated rejection to the authors and also sends copies of the peer reviews to the Ministry of Education and Science of the Russian Federation if a request has been received by the Editorial Board.
In some cases, the Editorial Board can send the article for an additional peer review, including statistical and methodological reviewing.
The Editorial Board constantly monitors the quality of peer review using the Russian version of the Review Quality Instrument questionnaire (Version 3.2), van Rooyen S., Black N., Godlee F. J Clin Epidemiol 1999;52:625-9.
The Russian version of the Review Quality Instrument questionnaire is available here (download - MS Word .doc).
The Editorial Board of the journal expects that the review process will help to:
Advertising and sponsorship are important to our journals in helping us to provide value for our users.
Our readers and customers expect us to be trustworthy and independent, so our advertising should support that expectation.
Media Sphere (including all of our journals published) accepts advertising for products and services that are mostly of an interest to users in their professional activities ( such as OTC & Rx drugs, medical equipment etc). Advertisements and sponsorship must be legal, truthful and comply with the relevant laws & regulations of the Russian Federation.
Our users should immediately be able to distinguish between advertising and editorial content.
Sponsored content should be clearly identifiable. The nature of any commercial relationship must be transparent to our users.
Our advertising policy does not allow advertising or sponsorship to influence editorial decisions.
Online advertising or sponsorship should not impede users’ access to editorial content.
We accept advertising and sponsorship from competitors.
We do not accept advertising of uncertified drugs and equipment.
We do not accept advertising or sponsorship relating to tobacco products, or to products and services from tobacco companies, and alcohol, as well as their related companies and funds.
Advertising and sponsorship are subject to publishers’ oversight.
If a proposal is refused for reasons outside these guidelines, Media Sphere will provide an explanation.
Buying the print version you get an access for electronic version of journal in your account.
The subscription price is for individuals.
For subscription fees and billing for legal entities, please send inquiries to: zakaz@mediasphera.ru
Please write the correct address when ordering the print version.
Email Confirmation
An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.
Email Confirmation
We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.